# Pediatric Patients Aged 1 to 6 Years With APDS

> **NCT05693129** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Pharming Technologies B.V.** · enrollment: 16 (actual)

## Conditions studied

- APDS

## Interventions

- **DRUG:** Leniolisib

## Key facts

- **NCT ID:** NCT05693129
- **Lead sponsor:** Pharming Technologies B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-30
- **Primary completion:** 2026-07-09
- **Final completion:** 2026-10-28
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-10-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05693129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05693129, "Pediatric Patients Aged 1 to 6 Years With APDS". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05693129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*